Table 1.

Relative distribution of proteins with Native PAGE after treatment with adrenaline.

Groups	Intensity, % (mean ± SD)							Ratio (A : G)
	Prealbumin	Albumin	α1-	α2-	β1-	β2-	γ-Globulins
C	2.66 ± 0.52	57.62 ± 3.80	5.19 ± 0.56	2.96 ± 1.62	15.89 ± 1.49	8.64 ± 0.79	7.04 ± 0.52	1.36 ± 0.22
A1	4.57 ± 0.57∗∗	54.32 ± 1.07	7.42 ± 1.03∗∗	5.34 ± 1.20∗	12.89 ± 0.70∗	6.24 ± 1.27∗	9.78 ± 1.38∗	1.20 ± 0.15
A2	3.66 ± 0.25	48.39 ± 3.72∗∗	8.53 ± 0.66∗∗	7.42 ± 1.36∗∗	11.50 ± 0.85∗∗	6.20 ± 1.28∗	9.43 ± 1.23	0.94 ± 0.22∗
A3	2.05 ± 0.32	46.86 ± 2.54∗∗	18.31 ± 3.01∗∗∗	5.31 ± 1.32∗	12.82 ± 1.52∗	4.26 ± 2.57∗∗	9.47 ± 1.56	0.88 ± 0.28∗
CP	3.69 ± 0.47∗	52.07 ± 1.25	6.07 ± 1.73	2.17 ± 1.52	16.14 ± 0.83	9.66 ± 0.84∗∗	9.11 ± 1.42	1.08 ± 0.23

^∗ P < 0.05, ^∗∗P < 0.01, and ^∗∗∗P < 0.001. C: control group, groups treated with adrenaline doses (A1, 0.75 mg/kg; A2, 1.5 mg/kg; and A3, 3 mg/kg body weight); CP: group treated with cyclophosphamide.